The in vitro study explores a strategy to limit the invasive capacity of metastatic breast cancer cells using iron oxide nanoparticles
Read more
Teams from the University of Barcelona and the University of Girona, in collaboration with Nanjing University (China), have developed an innovative method for selectively modifying these boron-rich mo...
Read more
The results of this study by Cima Universidad de Navarra help improve the accuracy of diagnosis and monitoring for patients with multiple myeloma and primary systemic amyloidosis
Read more
Researchers at VHIO have published an article in the journal European Journal of Cancer on the evolution of targeted therapies in early-phase clinical trials. The study shows a progressive improvement...
Read more
It has been demonstrated that eliminating mutated KRAS protein using PROTACs induces rapid tumour regression in mouse models of lung adenocarcinoma
Read more
The HERIZON-GEA-01 open-label, phase 3 clinical trial was designed to compare first-line treatment with the bispecific antibody zanidatamab plus chemotherapy with or without PD‐1 monoclonal antibody...
Read more
invResearchers have shown that a type of fat molecule, long associated with signalling at the cell's outer membrane, also operates inside the nucleus on a schedule that matches the rhythm of cell divi...
Read more
Han demostrado por primera vez que la administración de antibióticos de amplio espectro, antes de iniciar un tratamiento con anticuerpos biespecíficos —una forma avanzada de inmunoterapia—, se ...
Read more
Three out of four people selected to participate in a lung cancer screening programme because they were at high risk of developing the disease want to quit smoking, but almost 80% rule out quitting if...
Read more
This is the first trial of a diagnostic test that identifies, in blood plasma, a protein (AXL) that acts as a biomarker for pancreatic ductal adenocarcinoma, the most common and deadliest form of panc...
Read more
Oryzon Genomics a clinical-stage biopharmaceutical company and a global leader in epigenetics, today announced that the first patient has been enrolled in IDEAL, its Phase II study evaluating iadadems...
Read more
A team led by the UPV proposes harnessing the immunological memory generated by vaccination to help the body recognise and eliminate tumour cells
Read more
La mejor actitud que podemos adoptar es la de trat...
The research team observed changes in head circumf...
AtCDF3 gene induced greater production of sugars a...
En nuestro post hablamos sobre este interesante tipo de célula del...
Telum Therapeutics, a biotechnology company leveraging proprietary met...
